{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:24:01Z","timestamp":1762161841101},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.7759\/cureus.43533","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:08:52Z","timestamp":1692119332000},"source":"Crossref","is-referenced-by-count":2,"title":["Interventional Mental Health: A Transdisciplinary Approach to Novel Psychiatric Care Delivery"],"prefix":"10.7759","author":[{"given":"Jonathann","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Nicklay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Accreditation council for graduate medical education (ACGME) program requirements for graduate medical education in psychiatry. (2023). Accessed. May 20, 2023: https:\/\/www.acgme.org\/globalassets\/pfassets\/programrequirements\/400_psychiatry_2023.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1037\/tra0000383","article-title":"Comorbid mood and anxiety disorders and severity of posttraumatic stress disorder symptoms in treatment-seeking veterans","volume":"11","author":"Knowles KA","year":"2019","unstructured":"Knowles KA, Sripada RK, Defever M, Rauch SA. Comorbid mood and anxiety disorders and severity of posttraumatic stress disorder symptoms in treatment-seeking veterans. Psychol Trauma. 2019, 11:451-8. 10.1037\/tra0000383","journal-title":"Psychol Trauma"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.11.016","article-title":"The symptoms at the center: examining the comorbidity of posttraumatic stress disorder, generalized anxiety disorder, and depression with network analysis","volume":"109","author":"Price M","year":"2019","unstructured":"Price M, Legrand AC, Brier ZM, H\u00e9bert-Dufresne L. The symptoms at the center: examining the comorbidity of posttraumatic stress disorder, generalized anxiety disorder, and depression with network analysis. J Psychiatr Res. 2019, 109:52-8. 10.1016\/j.jpsychires.2018.11.016","journal-title":"J Psychiatr Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.2\/jflory","article-title":"Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations","volume":"17","author":"Flory JD","year":"2015","unstructured":"Flory JD, Yehuda R. Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin Neurosci. 2015, 17:141-50. 10.31887\/DCNS.2015.17.2\/jflory","journal-title":"Dialogues Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201904020","article-title":"Generalized anxiety disorder","volume":"170","author":"DeMartini J","year":"2019","unstructured":"DeMartini J, Patel G, Fancher TL. Generalized anxiety disorder. Ann Intern Med. 2019, 170:ITC49-64. 10.7326\/AITC201904020","journal-title":"Ann Intern Med"},{"key":"ref6","article-title":"Generalized anxiety disorder","author":"Munir S","year":"2022","unstructured":"Munir S, Takov V. Generalized anxiety disorder. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00064.2018","article-title":"Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety","volume":"120","author":"Holwerda SW","year":"2018","unstructured":"Holwerda SW, Luehrs RE, Gremaud AL, et al.. Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety. J Neurophysiol. 2018, 120:11-22. 10.1152\/jn.00064.2018","journal-title":"J Neurophysiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00220.2018","article-title":"Sympathetic activation in chronic anxiety: not just at the \"height\" of stress. Editorial Focus on \"Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety\"","volume":"120","author":"Wenner MM","year":"2018","unstructured":"Wenner MM. Sympathetic activation in chronic anxiety: not just at the \"height\" of stress. Editorial Focus on \"Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety\". J Neurophysiol. 2018, 120:7-8. 10.1152\/jn.00220.2018","journal-title":"J Neurophysiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.4225","article-title":"Association of generalized anxiety disorder with autonomic hypersensitivity and blunted ventromedial prefrontal cortex activity during peripheral adrenergic stimulation: a randomized clinical trial","volume":"79","author":"Teed AR","year":"2022","unstructured":"Teed AR, Feinstein JS, Puhl M, et al.. Association of generalized anxiety disorder with autonomic hypersensitivity and blunted ventromedial prefrontal cortex activity during peripheral adrenergic stimulation: a randomized clinical trial. JAMA Psychiatry. 2022, 79:323-32. 10.1001\/jamapsychiatry.2021.4225","journal-title":"JAMA Psychiatry"},{"key":"ref10","article-title":"Depression overview","volume":"1","author":"McCarter T","year":"2008","unstructured":"McCarter T. Depression overview. Am Health Drug Benefits. 2008, 1:44-51.","journal-title":"Am Health Drug Benefits"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2002.4.1\/bbondy","article-title":"Pathophysiology of depression and mechanisms of treatment","volume":"4","author":"Brigitta B","year":"2002","unstructured":"Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2002, 4:7-20. 10.31887\/DCNS.2002.4.1\/bbondy","journal-title":"Dialogues Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.6.651","article-title":"Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years","volume":"64","author":"Moffitt TE","year":"2007","unstructured":"Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007, 64:651-60. 10.1001\/archpsyc.64.6.651","journal-title":"Arch Gen Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-018-0179-0","article-title":"Posttraumatic stress disorder: from diagnosis to prevention","volume":"5","author":"Miao XR","year":"2018","unstructured":"Miao XR, Chen QB, Wei K, Tao KM, Lu ZJ. Posttraumatic stress disorder: from diagnosis to prevention. Mil Med Res. 2018, 5:32. 10.1186\/s40779-018-0179-0","journal-title":"Mil Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi KS","year":"2012","unstructured":"Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012, 6:369-88. 10.2147\/PPA.S29716","journal-title":"Patient Prefer Adherence"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12835","article-title":"Brain structure alterations in depression: psychoradiological evidence","volume":"24","author":"Zhang FF","year":"2018","unstructured":"Zhang FF, Peng W, Sweeney JA, Jia ZY, Gong QY. Brain structure alterations in depression: psychoradiological evidence. CNS Neurosci Ther. 2018, 24:994-1003. 10.1111\/cns.12835","journal-title":"CNS Neurosci Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1547-16.2016","article-title":"Ketamine: NMDA receptors and beyond","volume":"36","author":"Zorumski CF","year":"2016","unstructured":"Zorumski CF, Izumi Y, Mennerick S. Ketamine: NMDA receptors and beyond. J Neurosci. 2016, 36:11158-64. 10.1523\/JNEUROSCI.1547-16.2016","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00006.x","article-title":"Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain","volume":"13","author":"Siu A","year":"2007","unstructured":"Siu A, Drachtman R. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. CNS Drug Rev. 2007, 13:96-106. 10.1111\/j.1527-3458.2007.00006.x","journal-title":"CNS Drug Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell A","year":"2020","unstructured":"Adell A. Brain NMDA receptors in schizophrenia and depression. Biomolecules. 2020, 10:10.3390\/biom10060947","journal-title":"Biomolecules"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah CG","year":"2018","unstructured":"Abdallah CG, De Feyter HM, Averill LA, et al.. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018, 43:2154-60. 10.1038\/s41386-018-0136-3","journal-title":"Neuropsychopharmacology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19090915","article-title":"Distinct symptom-specific treatment targets for circuit-based neuromodulation","volume":"177","author":"Siddiqi SH","year":"2020","unstructured":"Siddiqi SH, Taylor SF, Cooke D, Pascual-Leone A, George MS, Fox MD. Distinct symptom-specific treatment targets for circuit-based neuromodulation. Am J Psychiatry. 2020, 177:435-46. 10.1176\/appi.ajp.2019.19090915","journal-title":"Am J Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01246-3","article-title":"Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors","volume":"26","author":"Lazarevic V","year":"2021","unstructured":"Lazarevic V, Yang Y, Flais I, Svenningsson P. Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol Psychiatry. 2021, 26:7425-35. 10.1038\/s41380-021-01246-3","journal-title":"Mol Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen S","year":"2008","unstructured":"Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008, 64:527-32. 10.1016\/j.biopsych.2008.05.005","journal-title":"Biol Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.113","article-title":"Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression","volume":"17","author":"Guilloux JP","year":"2012","unstructured":"Guilloux JP, Douillard-Guilloux G, Kota R, et al.. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry. 2012, 17:1130-42. 10.1038\/mp.2011.113","journal-title":"Mol Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang T","year":"2020","unstructured":"Yang T, Nie Z, Shu H, et al.. The role of BDNF on neural plasticity in depression. Front Cell Neurosci. 2020, 14:82. 10.3389\/fncel.2020.00082","journal-title":"Front Cell Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial","volume":"179","author":"Cole EJ","year":"2022","unstructured":"Cole EJ, Phillips AL, Bentzley BS, et al.. Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial. Am J Psychiatry. 2022, 179:132-41. 10.1176\/appi.ajp.2021.20101429","journal-title":"Am J Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1640604","article-title":"Esketamine for treatment resistant depression","volume":"19","author":"Swainson J","year":"2019","unstructured":"Swainson J, Thomas RK, Archer S, et al.. Esketamine for treatment resistant depression. Expert Rev Neurother. 2019, 19:899-911. 10.1080\/14737175.2019.1640604","journal-title":"Expert Rev Neurother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13714","article-title":"Prevalence, correlates, and treatment of suicidal behavior in US military veterans: results from the 2019-2020 National Health and Resilience in Veterans Study","volume":"82","author":"Nichter B","year":"2021","unstructured":"Nichter B, Stein MB, Norman SB, Hill ML, Straus E, Haller M, Pietrzak RH. Prevalence, correlates, and treatment of suicidal behavior in US military veterans: results from the 2019-2020 National Health and Resilience in Veterans Study. J Clin Psychiatry. 2021, 82:10.4088\/JCP.20m13714","journal-title":"J Clin Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.01998","article-title":"Posttraumatic stress disorder, suicidal ideation, and suicidal self-directed violence among U.S. military personnel and veterans: a systematic review of the literature from 2010 to 2018","volume":"11","author":"Holliday R","year":"2020","unstructured":"Holliday R, Borges LM, Stearns-Yoder KA, Hoffberg AS, Brenner LA, Monteith LL. Posttraumatic stress disorder, suicidal ideation, and suicidal self-directed violence among U.S. military personnel and veterans: a systematic review of the literature from 2010 to 2018. Front Psychol. 2020, 11:1998. 10.3389\/fpsyg.2020.01998","journal-title":"Front Psychol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2013.06.003","article-title":"The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample","volume":"36","author":"Husarewycz MN","year":"2014","unstructured":"Husarewycz MN, El-Gabalawy R, Logsetty S, Sareen J. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry. 2014, 36:26-32. 10.1016\/j.genhosppsych.2013.06.003","journal-title":"Gen Hosp Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2013.02.013","article-title":"Interventions to prevent post-traumatic stress disorder: a systematic review","volume":"44","author":"Forneris CA","year":"2013","unstructured":"Forneris CA, Gartlehner G, Brownley KA, et al.. Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med. 2013, 44:635-50. 10.1016\/j.amepre.2013.02.013","journal-title":"Am J Prev Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20656","article-title":"Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges","volume":"18","author":"Bryant RA","year":"2019","unstructured":"Bryant RA. Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges. World Psychiatry. 2019, 18:259-69. 10.1002\/wps.20656","journal-title":"World Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s1047-9651(18)30066-4","article-title":"Anatomy of the peripheral nervous system","volume":"12","author":"Goldstein B","year":"2001","unstructured":"Goldstein B. Anatomy of the peripheral nervous system. Phys Med Rehabil Clin N Am. 2001, 12:207-36. 10.1016\/s1047-9651(18)30066-4","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio D","year":"2021","unstructured":"De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. J Neurosci. 2021, 41:891-900. 10.1523\/JNEUROSCI.1659-20.2020","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5698","article-title":"Detection of the stellate and thoracic sympathetic chain ganglia with high-resolution 3D-CISS MR imaging","volume":"39","author":"Chaudhry A","year":"2018","unstructured":"Chaudhry A, Kamali A, Herzka DA, Wang KC, Carrino JA, Blitz AM. Detection of the stellate and thoracic sympathetic chain ganglia with high-resolution 3D-CISS MR imaging. AJNR Am J Neuroradiol. 2018, 39:1550-4. 10.3174\/ajnr.A5698","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ar.23797","article-title":"Morphological spectra of adult human stellate ganglia: implications for thoracic sympathetic denervation","volume":"301","author":"Kwon OJ","year":"2018","unstructured":"Kwon OJ, Pendekanti S, Fox JN, et al.. Morphological spectra of adult human stellate ganglia: implications for thoracic sympathetic denervation. Anat Rec (Hoboken). 2018, 301:1244-50. 10.1002\/ar.23797","journal-title":"Anat Rec (Hoboken)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2011.06.021","article-title":"Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression","volume":"77","author":"Marsden WN","year":"2011","unstructured":"Marsden WN. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression. Med Hypotheses. 2011, 77:508-28. 10.1016\/j.mehy.2011.06.021","journal-title":"Med Hypotheses"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2016.04.019","article-title":"Neuroimaging genetic approaches to posttraumatic stress disorder","volume":"284","author":"Lebois LA","year":"2016","unstructured":"Lebois LA, Wolff JD, Ressler KJ. Neuroimaging genetic approaches to posttraumatic stress disorder. Exp Neurol. 2016, 284:141-52. 10.1016\/j.expneurol.2016.04.019","journal-title":"Exp Neurol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1807","article-title":"Stellate ganglion block treats posttraumatic stress: an example of precision mental health","volume":"10","author":"Lynch JH","year":"2020","unstructured":"Lynch JH. Stellate ganglion block treats posttraumatic stress: an example of precision mental health. Brain Behav. 2020, 10:e01807. 10.1002\/brb3.1807","journal-title":"Brain Behav"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s40479-021-00148-8","article-title":"Development of the new CPTSD diagnosis for ICD-11","volume":"8","author":"Maercker A","year":"2021","unstructured":"Maercker A. Development of the new CPTSD diagnosis for ICD-11. Borderline Personal Disord Emot Dysregul. 2021, 8:7. 10.1186\/s40479-021-00148-8","journal-title":"Borderline Personal Disord Emot Dysregul"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22457","article-title":"Treating adults with complex posttraumatic stress disorder using a modular approach to treatment: rationale, evidence, and directions for future research","volume":"32","author":"Karatzias T","year":"2019","unstructured":"Karatzias T, Cloitre M. Treating adults with complex posttraumatic stress disorder using a modular approach to treatment: rationale, evidence, and directions for future research. J Trauma Stress. 2019, 32:870-6. 10.1002\/jts.22457","journal-title":"J Trauma Stress"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-15-00518","article-title":"Effect of stellate ganglion block on specific symptom clusters for treatment of post-traumatic stress disorder","volume":"181","author":"Lynch JH","year":"2016","unstructured":"Lynch JH, Mulvaney SW, Kim EH, de Leeuw JB, Schroeder MJ, Kane SF. Effect of stellate ganglion block on specific symptom clusters for treatment of post-traumatic stress disorder. Mil Med. 2016, 181:1135-41. 10.7205\/MILMED-D-15-00518","journal-title":"Mil Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2009.01.009","article-title":"A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD)","volume":"72","author":"Lipov EG","year":"2009","unstructured":"Lipov EG, Joshi JR, Sanders S, Slavin KV. A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD). Med Hypotheses. 2009, 72:657-61. 10.1016\/j.mehy.2009.01.009","journal-title":"Med Hypotheses"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-12-00290","article-title":"Stellate ganglion block improves refractory post-traumatic stress disorder and associated memory dysfunction: a case report and systematic literature review","volume":"178","author":"Lipov EG","year":"2013","unstructured":"Lipov EG, Navaie M, Brown PR, Hickey AH, Stedje-Larsen ET, McLay RN. Stellate ganglion block improves refractory post-traumatic stress disorder and associated memory dysfunction: a case report and systematic literature review. Mil Med. 2013, 178:e260-4. 10.7205\/MILMED-D-12-00290","journal-title":"Mil Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2020-001693","article-title":"Behavioral health clinicians endorse stellate ganglion block as a valuable intervention in the treatment of trauma-related disorders","volume":"69","author":"Lynch JH","year":"2021","unstructured":"Lynch JH, Muench PD, Okiishi JC, Means GE, Mulvaney SW. Behavioral health clinicians endorse stellate ganglion block as a valuable intervention in the treatment of trauma-related disorders. J Investig Med. 2021, 69:989-93. 10.1136\/jim-2020-001693","journal-title":"J Investig Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab056","article-title":"The successful use of left-sided stellate ganglion block in patients that fail to respond to right-sided stellate ganglion block for the treatment of post-traumatic stress disorder symptoms: a retrospective analysis of 205 patients","volume":"187","author":"Mulvaney SW","year":"2022","unstructured":"Mulvaney SW, Lynch JH, Curtis KE, Ibrahim TS. The successful use of left-sided stellate ganglion block in patients that fail to respond to right-sided stellate ganglion block for the treatment of post-traumatic stress disorder symptoms: a retrospective analysis of 205 patients. Mil Med. 2022, 187:e826-9. 10.1093\/milmed\/usab056","journal-title":"Mil Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3474","article-title":"Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial","volume":"77","author":"Rae Olmsted KL","year":"2020","unstructured":"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al.. Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Psychiatry. 2020, 77:130-8. 10.1001\/jamapsychiatry.2019.3474","journal-title":"JAMA Psychiatry"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-14-00151","article-title":"Stellate ganglion block used to treat symptoms associated with combat-related post-traumatic stress disorder: a case series of 166 patients","volume":"179","author":"Mulvaney SW","year":"2014","unstructured":"Mulvaney SW, Lynch JH, Hickey MJ, Rahman-Rawlins T, Schroeder M, Kane S, Lipov E. Stellate ganglion block used to treat symptoms associated with combat-related post-traumatic stress disorder: a case series of 166 patients. Mil Med. 2014, 179:1133-40. 10.7205\/MILMED-D-14-00151","journal-title":"Mil Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.47739\/2334-2307\/1163","article-title":"Comparison C6 stellate ganglion versus C6 and C4 cervical sympathetic chain blocks for treatment of posttraumatic stress disorder (PTSD): analysis of 147 patients","volume":"7","author":"Mulvaney SW","year":"2020","unstructured":"Mulvaney SW, Curtis KE, Ibrahim TS. Comparison C6 stellate ganglion versus C6 and C4 cervical sympathetic chain blocks for treatment of posttraumatic stress disorder (PTSD): analysis of 147 patients. J Neurol Disord Stroke. 2020, 7:1163. 10.47739\/2334-2307\/1163","journal-title":"J Neurol Disord Stroke"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4236\/ojanes.2013.33033","article-title":"Different effects of right and left stellate ganglion block on systolic blood pressure and heart rate","volume":"3","author":"Yokota S","year":"2013","unstructured":"Yokota S, Taneyama C, Goto H. Different effects of right and left stellate ganglion block on systolic blood pressure and heart rate. Open J Anesthesiol. 2013, 3:143-7. 10.4236\/ojanes.2013.33033","journal-title":"Open J Anesthesiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_484_18","article-title":"Efficacy of ketamine therapy in the treatment of depression","volume":"61","author":"Mandal S","year":"2019","unstructured":"Mandal S, Sinha VK, Goyal N. Efficacy of ketamine therapy in the treatment of depression. Indian J Psychiatry. 2019, 61:480-5. 10.4103\/psychiatry.IndianJPsychiatry_484_18","journal-title":"Indian J Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019","volume":"277","author":"Marcantoni WS","year":"2020","unstructured":"Marcantoni WS, Akoumba BS, Wassef M, Mayrand J, Lai H, Richard-Devantoy S, Beauchamp S. A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019. J Affect Disord. 2020, 277:831-41. 10.1016\/j.jad.2020.09.007","journal-title":"J Affect Disord"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2011.08.008","article-title":"Overview of glutamatergic neurotransmission in the nervous system","volume":"100","author":"Niciu MJ","year":"2012","unstructured":"Niciu MJ, Kelmendi B, Sanacora G. Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav. 2012, 100:656-64. 10.1016\/j.pbb.2011.08.008","journal-title":"Pharmacol Biochem Behav"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips JL","year":"2019","unstructured":"Phillips JL, Norris S, Talbot J, et al.. Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry. 2019, 176:401-9. 10.1176\/appi.ajp.2018.18070834","journal-title":"Am J Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh JB","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly EJ, et al.. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016, 173:816-26. 10.1176\/appi.ajp.2016.16010037","journal-title":"Am J Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00401","article-title":"The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity","volume":"8","author":"Chater TE","year":"2014","unstructured":"Chater TE, Goda Y. The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity. Front Cell Neurosci. 2014, 8:401. 10.3389\/fncel.2014.00401","journal-title":"Front Cell Neurosci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704712","article-title":"Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes","volume":"136","author":"Marchi M","year":"2002","unstructured":"Marchi M, Raiteri L, Risso F, et al.. Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol. 2002, 136:434-40. 10.1038\/sj.bjp.0704712","journal-title":"Br J Pharmacol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814709116","article-title":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine","volume":"116","author":"Fukumoto K","year":"2019","unstructured":"Fukumoto K, Foga\u00e7a MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine. Proc Natl Acad Sci U S A. 2019, 116:297-302. 10.1073\/pnas.1814709116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis","volume":"134","author":"Xiong J","year":"2021","unstructured":"Xiong J, Lipsitz O, Chen-Li D, et al.. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis. J Psychiatr Res. 2021, 134:57-68. 10.1016\/j.jpsychires.2020.12.038","journal-title":"J Psychiatr Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.11.020","article-title":"The effects of ketamine on cognition in treatment-resistant depression: a systematic review and priority avenues for future research","volume":"120","author":"Gill H","year":"2021","unstructured":"Gill H, Gill B, Rodrigues NB, et al.. The effects of ketamine on cognition in treatment-resistant depression: a systematic review and priority avenues for future research. Neurosci Biobehav Rev. 2021, 120:78-85. 10.1016\/j.neubiorev.2020.11.020","journal-title":"Neurosci Biobehav Rev"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2006.8.2\/fduval","article-title":"Treatments in depression","volume":"8","author":"Duval F","year":"2006","unstructured":"Duval F, Lebowitz BD, Macher JP. Treatments in depression. Dialogues Clin Neurosci. 2006, 8:191-206. 10.31887\/DCNS.2006.8.2\/fduval","journal-title":"Dialogues Clin Neurosci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_88_18","article-title":"Transcranial magnetic stimulation: a review of its evolution and current applications","volume":"27","author":"Chail A","year":"2018","unstructured":"Chail A, Saini RK, Bhat PS, Srivastava K, Chauhan V. Transcranial magnetic stimulation: a review of its evolution and current applications. Ind Psychiatry J. 2018, 27:172-80. 10.4103\/ipj.ipj_88_18","journal-title":"Ind Psychiatry J"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S276635","article-title":"Transcranial magnetic stimulation (TMS) safety with respect to seizures: a literature review","volume":"16","author":"Stultz DJ","year":"2020","unstructured":"Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R. Transcranial magnetic stimulation (TMS) safety with respect to seizures: a literature review. Neuropsychiatr Dis Treat. 2020, 16:2989-3000. 10.2147\/NDT.S276635","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3956(01)00023-1","article-title":"Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?","volume":"35","author":"Post A","year":"2001","unstructured":"Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?. J Psychiatr Res. 2001, 35:193-215. 10.1016\/s0022-3956(01)00023-1","journal-title":"J Psychiatr Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/da.21969","article-title":"Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice","volume":"29","author":"Carpenter LL","year":"2012","unstructured":"Carpenter LL, Janicak PG, Aaronson ST, et al.. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012, 29:587-96. 10.1002\/da.21969","journal-title":"Depress Anxiety"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0315","article-title":"Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial","volume":"69","author":"Avery DH","year":"2008","unstructured":"Avery DH, Isenberg KE, Sampson SM, et al.. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008, 69:441-51. 10.4088\/jcp.v69n0315","journal-title":"J Clin Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08977","article-title":"A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period","volume":"75","author":"Dunner DL","year":"2014","unstructured":"Dunner DL, Aaronson ST, Sackeim HA, et al.. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014, 75:1394-401. 10.4088\/JCP.13m08977","journal-title":"J Clin Psychiatry"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2010.07.003","article-title":"Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study","volume":"3","author":"Janicak PG","year":"2010","unstructured":"Janicak PG, Nahas Z, Lisanby SH, et al.. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010, 3:187-99. 10.1016\/j.brs.2010.07.003","journal-title":"Brain Stimul"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.1.57","article-title":"The STAR*D study: treating depression in the real world","volume":"75","author":"Gaynes BN","year":"2008","unstructured":"Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008, 75:57-66. 10.3949\/ccjm.75.1.57","journal-title":"Cleve Clin J Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.08.005","article-title":"Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation","volume":"277","author":"Sackeim HA","year":"2020","unstructured":"Sackeim HA, Aaronson ST, Carpenter LL, et al.. Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation. J Affect Disord. 2020, 277:65-74. 10.1016\/j.jad.2020.08.005","journal-title":"J Affect Disord"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough JW","year":"2013","unstructured":"Murrough JW, Perez AM, Pillemer S, et al.. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013, 74:250-6. 10.1016\/j.biopsych.2012.06.022","journal-title":"Biol Psychiatry"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4736","article-title":"Use of transcranial magnetic stimulation for depression","volume":"11","author":"Rizvi S","year":"2019","unstructured":"Rizvi S, Khan AM.  Use of transcranial magnetic stimulation for depression. Cureus. 2019, 11:e4736. 10.7759\/cureus.4736","journal-title":"Cureus"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.86598","article-title":"Stellate ganglion block for treatment of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage - a preliminary study","volume":"27","author":"Jain V","year":"2011","unstructured":"Jain V, Rath GP, Dash HH, Bithal PK, Chouhan RS, Suri A. Stellate ganglion block for treatment of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage - a preliminary study. J Anaesthesiol Clin Pharmacol. 2011, 27:516-21. 10.4103\/0970-9185.86598","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref73","article-title":"Serial stellate ganglion blocks for intractable postherpetic itching in a pediatric patient: a case report","volume":"12","author":"Peterson RC","year":"2009","unstructured":"Peterson RC, Patel L, Cubert K, Gulati A. Serial stellate ganglion blocks for intractable postherpetic itching in a pediatric patient: a case report. Pain Physician. 2009, 12:629-32.","journal-title":"Pain Physician"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199104000-00024","article-title":"Stellate ganglion blocks in pediatric patients","volume":"72","author":"Parris WC","year":"1991","unstructured":"Parris WC, Reddy BC, White HW, McGrath DM. Stellate ganglion blocks in pediatric patients. Anesth Analg. 1991, 72:552-6. 10.1213\/00000539-199104000-00024","journal-title":"Anesth Analg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"178","author":"Dwyer JB","year":"2021","unstructured":"Dwyer JB, Landeros-Weisenberger A, Johnson JA, et al.. Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial. Am J Psychiatry. 2021, 178:352-62. 10.1176\/appi.ajp.2020.20010018","journal-title":"Am J Psychiatry"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2018.0030","article-title":"Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study","volume":"28","author":"Cullen KR","year":"2018","unstructured":"Cullen KR, Amatya P, Roback MG, et al.. Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study. J Child Adolesc Psychopharmacol. 2018, 28:437-44. 10.1089\/cap.2018.0030","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref77","article-title":"Use of repetitive transcranial magnetic stimulation in child psychiatry","volume":"19","author":"Bejenaru AM","year":"2022","unstructured":"Bejenaru AM, Malhi NK. Use of repetitive transcranial magnetic stimulation in child psychiatry. Innov Clin Neurosci. 2022, 19:11-22.","journal-title":"Innov Clin Neurosci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0600-3","article-title":"Transcranial magnetic stimulation for the treatment of pediatric neurological disorders","volume":"21","author":"Malone LA","year":"2019","unstructured":"Malone LA, Sun LR. Transcranial magnetic stimulation for the treatment of pediatric neurological disorders. Curr Treat Options Neurol. 2019, 21:58. 10.1007\/s11940-019-0600-3","journal-title":"Curr Treat Options Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/170322-interventional-mental-health-a-transdisciplinary-approach-to-novel-psychiatric-care-delivery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:18Z","timestamp":1707508998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/170322-interventional-mental-health-a-transdisciplinary-approach-to-novel-psychiatric-care-delivery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.43533","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}